OTCM
UNICY
Market cap10bUSD
Jul 09, Last price
2.90USD
1D
-2.68%
1Q
-2.68%
Jan 2017
-19.82%
Name
Unicharm Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Unicharm Corporation engages in the manufacturing and sale of pet care and related products in Japan and internationally. The company operates through Personal Care, Pet Care, and Others segments. It offers wellness care, feminine care, baby and child care products, as well as food-packaging materials, etc. The company also provides napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree brand name; specialized liners for incontinence care under the Charm Nap brand name; fabric and facial masks under the Chorittai and Chokaiteki Mask brand name; Home care products under Wave brand; and kitchen paper towel under the Cook Up brand name. In addition, it offers pet food under the Pet Dog Genki, Pet Cat Genki, Grand Deli, Best Balance, Silver Spoon, Silver Plate, AllWell, and Physicalife brand names, as well as excrement cleanup sheets, disposable diapers, apparel-like absorption wear for excretion-care for dogs, and Deo-Sand series and Deo-Toilet system products for cats. Further, the company provides feminine care products including feminine napkins, tampons, sanitary shorts, and panty liners under the Sofy and Silcot names; and disposable baby diaper under the Moony, Mamy Poko, Trepanman, and Oyasuminman brands. Additionally, it is involved in recycling of disposable diapers, as well as offering products under RefF brand. Unicharm Corporation was incorporated in 1941 and is headquartered in Minato, Japan.
IPO date
Aug 02, 1976
Employees
16,206
Domiciled in
JP
Incorporated in
JP
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||